170
Views
23
CrossRef citations to date
0
Altmetric
Review

Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles

Pages 57-64 | Published online: 06 Jan 2015

References

  • PathanSAIqbalZZaidiSMCNS drug delivery systems: novel approachesRecent Pat Drug Deliv Formul200931718919149731
  • XiaHGaoXGuGLow molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administrationBiomaterials201132369888989821937105
  • TosiGCostantinoLRivasiFTargeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123J Control Release200712211917651855
  • KreuterJNanoparticulate system for brain delivery of drugsAdv Drug Deliv Rev2001471658111251246
  • DhuriaSVHansonLRFreyWH2ndIntranasal delivery to the central nervous system: mechanisms and experimental considerationsJ Pharm Sci20109941654167319877171
  • ThorneRGFreyWH2ndDelivery of neurotrophic factors to the central nervous system: pharmacokinetic considerationsClin Pharmacokinet2001401290794611735609
  • IllumLTransport of drugs from the nasal cavity to the central nervous systemEur J Pharm Sci200011111810913748
  • IllumLIs nose-to-brain transport of drugs in man a reality?J Pharm Pharmacol200456131714979996
  • MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
  • ThorneRGPronkGJPadmanabhanVFreyWH2ndDelivery of insulin-like growth factor-1 to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administrationNeuroscience2004127248149615262337
  • LochheadJJThorneRGIntranasal delivery of biologics to the central nervous systemAdv Drug Deliv Rev201164761462822119441
  • DjupeslandPGMessinaJCMahmoudRAThe nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overviewTher Deliv20145670973325090283
  • ChapmanCDFreyWH2ndCraftSIntranasal treatment of central nervous system dysfunction in humansPharm Res201230102475248423135822
  • MerkusFWVan Den BergMPCan nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theoryDrugs R D20078313314417472409
  • ShingakiTInoueDFurubayashiTTransnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapyMol Pharm2010751561156820695463
  • SakaneTYamashitaSYataNSezakiHTransnasal delivery of 5-fluorouracil to the brain in the ratJ Drug Target19997323324010680979
  • ThorneRGHansonLRRossTMTungDFreyWH2ndDelivery of interferon-beta to the monkey nervous system following intranasal administrationNeuroscience2008153278579718304744
  • Alcalá-BarrazaSRLeeMSHansonLRMcDonaldAAFreyWH2ndMcLoonLKIntranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNSJ Drug Target201018317919019807216
  • YangJPLiuHJChengSMDirect transport of VEGF from the nasal cavity to brainNeurosci Lett2009449210811118996442
  • RennerDBFreyWH2ndHansonLRIntranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathwayNeurosci Lett2012513219319722387067
  • NishinaKMizusawaHYokotaTShort interfering RNA and the central nervous system: development of nonviral delivery systemsExpert Opin Drug Deliv201310328929223289737
  • DanielyanLSchäferRvon Ameln-MayerhoferAIntranasal delivery of cells to the brainEur J Cell Biol200988631532419324456
  • DanielyanLSchäferRvon Ameln-MayerhoferATherapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson diseaseRejuvenation Res201114131621291297
  • van VelthovenCTSheldonRAKavelaarsAMesenchymal stem cell transplantation attenuates brain injury after neonatal strokeStroke20134451426143223539530
  • KernWBornJSchreiberHFehmHLCentral nervous system effects of intranasally administered insulin during euglycemia in menDiabetes199948355756310078556
  • BenedictCHallschmidMHatkeAIntranasal insulin improves memory in humansPsychoneuroendocrinology200429101326133415288712
  • BenedictCKernWSchultesBBornJHallschmidMDifferential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulinJ Clin Endocrinol Metab20089341339134418230654
  • BenedictCBredeSSchiothHBIntranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy menDiabetes201160111411820876713
  • RegerMAWatsonGSGreenPSIntranasal insulin improves cognition and modulates beta-amyloid in early ADNeurology200870644044817942819
  • BornJLangeTKernWMcGregorGPBickelUFehmHLSniffing neuropeptides:a transnasal approach to the human brainNat Neurosci20025651451611992114
  • FehmHLSmolnikRKernWMcGregorGPBickelUBornJThe melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4–10) decreases body fat in humansJ Clin Endocrinol Metabol200186311441148
  • SmolnikRPerrasBMolleMFehmHLBornJEvent-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4–10 and desacetyl-alpha-melanocyte stimulating hormoneJ Clin Psychopharmacol200020444545410917406
  • HallschmidMSmolnikRMcGregorGBornJFehmHLOverweight humans are resistant to the weight-reducing effects of melanocortin 4–10J Clin Endocrinol Metabol2006912522525
  • DeradIWillekeKPietrowskyRBornJFehmHLIntranasal angiotensin II directly influences central nervous regulation of blood pressureAm J Hypertens1998118 Pt 19719779715790
  • PietrowskyRStrubenCMolleMFehmHLBornJBrain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose–brain pathway for peptide effects in humansBiol Psychiatry19963953323408704064
  • KosfeldMHeinrichsMZakPJFischbacherUFehrEOxytocin increases trust in humansNature2005435704267367615931222
  • KirschPEsslingerCChenQOxytocin modulates neural circuitry for social cognition and fear in humansJ Neurosci20052549114891149316339042
  • DomesGHeinrichsMMichelABergerCHerpertzSCOxytocin improves “mind-reading” in humansBiol Psychiatry200761673173317137561
  • HeinrichsMBaumgartnerTKirschbaumCEhlertUSocial support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stressBiol Psychiatry200354121389139814675803
  • LabuschagneIPhanKLWoodAOxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorderNeuropsychopharmacology201035122403241320720535
  • GuastellaAJEinfeldSLGrayKMIntranasal oxytocin improves emotion recognition for youth with autism spectrum disordersBiol Psychiatry201067769269419897177
  • LalatsaASchatzleinAGUchegbuIFStrategies to deliver peptide drugs to the brainMol Pharm20141141081109324601686
  • DhandaDSFreyWH2ndLeopoldDKompellaUBApproaches for drug deposition in the human olfactory epitheliumDrug Deliv Technol200556472
  • KanazawaTTakiHTanakaKTakashimaYOkadaHCell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administrationPharm Res20112892130213921499835
  • TakiHKanazawaTAkiyamaFTakashimaYOkadaHIntranasal delivery of camptothecin-loaded Tat-modified nanomicells for treatment of intracranial brain tumorsPharmaceuticals20125101092110224281259
  • KanazawaTAkiyamaFKakizakiSTakashimaYSetaYDelivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micellesBiomaterials201334369220922623992922
  • KanazawaTMorisakiKSuzukiSTakashimaYProlongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micellesMol Pharm20141151471147824708261
  • AllenCYuYMaysingerDEisenbergAPoly caprolactone– b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818Bioconjug Chem2008955645729736490
  • OtsukaHNagasakiYKataokaKPEGylated nanoparticles for biological and pharmaceutical applicationsAdv Drug Deliv Rev200355340341912628324
  • JangJSKimSYLeeSBKimKOHanJSLeeYMPoly(ethylene glycol)/poly (ε-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfectionJ Control Release2006113217318216750279
  • ShinIGKimSYLeeYMChoCSSungYKMethoxy poly(ethylene gricol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterizationJ Control Release19985111119685899
  • KakizawaYKataokaKBlock copolymer micelles for delivery of gene and related compoundsAdv Drug Deliv Rev200254220322211897146
  • SharmaRLeeJSBettencourtRCXiaoCKoniecznySFWonYYEffects of the incorporation of hydrophobic middle block into a PEG–polycation diblock copolymer on the physicochemical and cell interaction properties of the polymer–DNA complexesBiomacromolecules20089113294330718942877
  • BrookingJDavisSSIllumLTransport of nanoparticles across the rat nasal mucosaJ Drug Target20019426727911697030
  • YangSColesDJEspositoAMitchellDJTothIMinchinRFCellular uptake of self-assembled cationic peptide-DNA complex: multifunctional role of the enhancer chloroquineJ Control Release2009135215916519171168
  • RajagopalanRXavierJRangarajNRaoNMGopalVRecombinant fusion proteins TAT-Mu. Mu and Mu-Mu mediate efficient non viral gene deliveryJ Gene Med20079427528617397090
  • ChenSGeXChenYLvNLiuYuanWAdvances with RNA interference in Alzheimer’s disease researchDrug Des Devel Ther20137117125
  • PiweckaMRolleKWyszkoENucleic acid-based technologies in therapy of malignant gliomasCurr Pharm Biotechnol20111211180521902632
  • OrlacchioABernardiGOrlacchioAMartinoSRNA interference as a tool for Alzheimer’s disease therapyMini Rev Med Chem20077111166117618045220
  • PappasTCBaderAGAndrussBFBrownDFordLPApplying small RNA molecules to the directed treatment of human diseases: realizing the potentialExpert Opin Ther Targets200812111512718076375
  • DykxhoornDMRNA interference as an anticancer therapy:patent perspectiveExpert Opin Ther Pat200919447549119441927